VELTRA, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 77%
7048 VELTRA Corporation 【J-GAAP】
Earnings ReportVELTRA Corporation <7048> [TSE Growth] announced its financial results after the market closed on November 14th (15:31). The consolidated ordinary profit/loss for the cumulative third quarter of the fiscal year ending December 2025 (January to September) turned into a profit of 87 million yen (compared to a loss of 334 million yen in the same period last year).
However, the full-year forecast for consolidated ordinary profit has decreased 77.1%, from the previous forecast of 480 million yen to 110 million yen (compared to a loss of 298 million yen in the previous period).
Based on the full-year plan announced by the company after the downward revision, our estimate of the consolidated ordinary profit for the July to December period (second half) has decreased 63.4%, from the previous forecast of 584 million yen to 214 million yen (compared to a loss of 13 million yen in the same period of the previous year).
In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a profit of 191 million yen (compared to a loss of 49 million yen in the same period last year). The operating profit/loss margin drastically improved from -3.2% in the same period last year to 13.5%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,228M | -84M | -133M | -172M | -4.8 | ー | Nov 14, 2023 | J-GAAP |
|
|
3,201M | -242M | -334M | -319M | -8.8 | ー | Nov 14, 2024 | J-GAAP |
|
|
3,438M | 92M | 87M | 86M | 2.4 | 79.1 | Nov 14, 2025 | J-GAAP |
| YoY | +7.4% | - | - | - | - |
Guidance Update
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2025 Prev | 3,299M | 589M | 584M | 479M | 13.1 | 0 | Aug 14, 2025 | J-GAAP |
| Jul - Dec, 2025 New | 2,399M | 209M | 214M | 179M | 4.9 | 0 | Nov 14, 2025 | J-GAAP |
| Revision Rate | -27.3% | -64.5% | -63.4% | -62.6% | -62.6% |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Prev | 5,400M | 500M | 480M | 400M | 10.9 | 0 | Feb 14, 2025 | J-GAAP |
| Dec, 2025 New | 4,500M | 120M | 110M | 100M | 2.7 | 0 | Nov 14, 2025 | J-GAAP |
| Revision Rate | -16.7% | -76.0% | -77.1% | -75.0% | -75.0% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
2,489M | 22M | -13M | -136M | -3.7 | 0 | Feb 14, 2025 | J-GAAP |
|
Guidance
Jul - Dec, 2025
|
2,399M | 209M | 214M | 179M | 4.9 | 0 | Nov 14, 2025 | J-GAAP |
| YoY | -3.6% | +850.0% | - | - | - |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
3,123M | -67M | -112M | -57M | -1.6 | 0 | Feb 14, 2024 | J-GAAP |
|
|
4,304M | -175M | -298M | -407M | -11.2 | 0 | Feb 14, 2025 | J-GAAP |
|
Guidance
Dec, 2025
|
4,500M | 120M | 110M | 100M | 2.7 | 0 | Nov 14, 2025 | J-GAAP |
| YoY | +4.6% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
1,386M | -45M | -49M | -48M | -1.3 | -3.2 | Nov 14, 2024 | J-GAAP |
|
|
1,103M | 67M | 36M | -88M | -2.4 | 6.1 | Feb 14, 2025 | J-GAAP |
|
|
1,131M | 56M | 36M | 27M | 0.8 | 5.0 | May 14, 2025 | J-GAAP |
|
|
970M | -145M | -140M | -106M | -2.9 | -14.9 | Aug 14, 2025 | J-GAAP |
|
|
1,337M | 181M | 191M | 165M | 4.5 | 13.5 | Nov 14, 2025 | J-GAAP |
| YoY | -3.5% | - | - | - | - |
Related Articles
-
Delta-Fly Pharma, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Fri Nov 14, 2025 3:35 pm JST Earnings -
Future Innovation Group, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 87%, Jul-Sep Ordinary Profit Increases by 5.8 times
Fri Nov 14, 2025 3:35 pm JST Earnings -
KLASS, 48% Increase in Ordinary Profit for The Current Fiscal Year
Fri Nov 14, 2025 3:35 pm JST Earnings -
Giken Holdings, First Half Ordinary Profit Increases by 51%, Jul-Sep Ordinary Profit Increases by 2.1 times
Fri Nov 14, 2025 3:35 pm JST Earnings -
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Fri Nov 14, 2025 3:32 pm JST Earnings -
LIFE CREATE, First Half Ordinary Profit Turns to Loss
Fri Nov 14, 2025 3:31 pm JST Earnings -
CRESTEC, Jul-Sep (1Q) Ordinary Profit Increases by 2.5 times
Fri Nov 14, 2025 3:31 pm JST Earnings -
eWeLL, Jul-Sep (3Q) Ordinary Profit Increases by 39%, Current Fiscal Year Dividend Revised Upward by 1 Yen
Fri Nov 14, 2025 3:31 pm JST Earnings -
Birdman, Jul-Sep (1Q) Net Income Loss Narrows
Fri Nov 14, 2025 3:30 pm JST Earnings -
Bleach Inc, Jul-Sep (1Q) Ordinary Profit Turns to Profit
Fri Nov 14, 2025 3:30 pm JST Earnings